Topics Panel Section
As the spread of the coronavirus (COVID-19) impacts manufacturing and supply chains around the world, companies have begun to assert that the outbreak excuses nonperformance under commercial contracts. Companies that are affected by the coronavirus should undertake a review with their counsel of the rights and obligations under various agreements and applicable law, including with respect to notice requirements, the potential impact on other agreements, insurance coverage and disclosure.
Despite substantial political and economic turmoil, the U.S. M&A market remained strong in 2019. The fundamentals support optimism for 2020, though headwinds could dampen activity.
SEC Adopts Amendments to the Accelerated Filer and Large Accelerated Filer DefinitionsMarch 31, 2020
Coronavirus/COVID-19: French Ordinance Enacts Moratorium on Statutes of Limitations, Procedural and Contractual DeadlinesMarch 31, 2020
Privacy & Cybersecurity Update – March 2020March 2020